The global residual DNA testing market is entering a period of steady expansion as biopharmaceutical manufacturers place greater emphasis on product purity, regulatory compliance, and advanced contamination detection. The market was valued at USD 309.3 million in 2025 and is projected to reach USD 525.3 million by 2033, expanding at a CAGR of 6.9% from 2026 to...